Record Information |
---|
Version | 5.0 |
---|
Status | Detected and Quantified |
---|
Creation Date | 2006-08-13 13:56:50 UTC |
---|
Update Date | 2023-07-07 20:53:58 UTC |
---|
HMDB ID | HMDB0004193 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Nudifloramide |
---|
Description | N-methyl-2-pyridone-5-carboxamide (2PY) is one of the end products of nicotinamide-adenine dinucleotide (NAD) degradation. Increased serum 2PY concentrations are observed in chronic renal failure (CRF) patients, which along with the deterioration of kidney function and its toxic properties (significant inhibition of PARP-1), suggests that 2PY is an uremic toxin. (PMID 12694300 ). 2PY has been identified as a uremic toxin according to the European Uremic Toxin Working Group (PMID: 22626821 ). |
---|
Structure | InChI=1S/C7H8N2O2/c1-9-4-5(7(8)11)2-3-6(9)10/h2-4H,1H3,(H2,8,11) |
---|
Synonyms | Value | Source |
---|
1-Methyl-5-carboxylamide-2-pyridone | ChEBI | N'-methyl-2-pyridone-5-carboxamide | ChEBI | N(1)-Methyl-2-pyridone-5-carboxamide | ChEBI | N-Methyl-2-pyridone-5-carboxamide | ChEBI | N'Methyl-2-pyridone-5-carboxamide | HMDB |
|
---|
Chemical Formula | C7H8N2O2 |
---|
Average Molecular Weight | 152.1506 |
---|
Monoisotopic Molecular Weight | 152.05857751 |
---|
IUPAC Name | 1-methyl-6-oxo-1,6-dihydropyridine-3-carboxamide |
---|
Traditional Name | 1-methyl-6-oxopyridine-3-carboxamide |
---|
CAS Registry Number | 701-44-0 |
---|
SMILES | CN1C=C(C=CC1=O)C(N)=O |
---|
InChI Identifier | InChI=1S/C7H8N2O2/c1-9-4-5(7(8)11)2-3-6(9)10/h2-4H,1H3,(H2,8,11) |
---|
InChI Key | JLQSXXWTCJPCBC-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as nicotinamides. These are heterocyclic aromatic compounds containing a pyridine ring substituted at position 3 by a carboxamide group. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Pyridines and derivatives |
---|
Sub Class | Pyridinecarboxylic acids and derivatives |
---|
Direct Parent | Nicotinamides |
---|
Alternative Parents | |
---|
Substituents | - Dihydropyridinecarboxylic acid derivative
- Nicotinamide
- Dihydropyridine
- Pyridinone
- Hydropyridine
- Heteroaromatic compound
- Lactam
- Carboximidic acid
- Carboximidic acid derivative
- Azacycle
- Organic nitrogen compound
- Organonitrogen compound
- Organooxygen compound
- Hydrocarbon derivative
- Organic oxide
- Organopnictogen compound
- Organic oxygen compound
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | |
---|
Disposition | |
---|
Process | |
---|
Role | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Experimental Collision Cross Sections |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
N1-Methyl-2-pyridone-5-carboxamide,1TMS,isomer #1 | CN1C=C(C(=O)N[Si](C)(C)C)C=CC1=O | 1782.7 | Semi standard non polar | 33892256 | N1-Methyl-2-pyridone-5-carboxamide,1TMS,isomer #1 | CN1C=C(C(=O)N[Si](C)(C)C)C=CC1=O | 1861.1 | Standard non polar | 33892256 | N1-Methyl-2-pyridone-5-carboxamide,1TMS,isomer #1 | CN1C=C(C(=O)N[Si](C)(C)C)C=CC1=O | 2139.7 | Standard polar | 33892256 | N1-Methyl-2-pyridone-5-carboxamide,2TMS,isomer #1 | CN1C=C(C(=O)N([Si](C)(C)C)[Si](C)(C)C)C=CC1=O | 1832.3 | Semi standard non polar | 33892256 | N1-Methyl-2-pyridone-5-carboxamide,2TMS,isomer #1 | CN1C=C(C(=O)N([Si](C)(C)C)[Si](C)(C)C)C=CC1=O | 1898.1 | Standard non polar | 33892256 | N1-Methyl-2-pyridone-5-carboxamide,2TMS,isomer #1 | CN1C=C(C(=O)N([Si](C)(C)C)[Si](C)(C)C)C=CC1=O | 2061.3 | Standard polar | 33892256 | N1-Methyl-2-pyridone-5-carboxamide,1TBDMS,isomer #1 | CN1C=C(C(=O)N[Si](C)(C)C(C)(C)C)C=CC1=O | 2041.5 | Semi standard non polar | 33892256 | N1-Methyl-2-pyridone-5-carboxamide,1TBDMS,isomer #1 | CN1C=C(C(=O)N[Si](C)(C)C(C)(C)C)C=CC1=O | 2086.8 | Standard non polar | 33892256 | N1-Methyl-2-pyridone-5-carboxamide,1TBDMS,isomer #1 | CN1C=C(C(=O)N[Si](C)(C)C(C)(C)C)C=CC1=O | 2260.7 | Standard polar | 33892256 | N1-Methyl-2-pyridone-5-carboxamide,2TBDMS,isomer #1 | CN1C=C(C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=CC1=O | 2338.6 | Semi standard non polar | 33892256 | N1-Methyl-2-pyridone-5-carboxamide,2TBDMS,isomer #1 | CN1C=C(C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=CC1=O | 2323.3 | Standard non polar | 33892256 | N1-Methyl-2-pyridone-5-carboxamide,2TBDMS,isomer #1 | CN1C=C(C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=CC1=O | 2236.5 | Standard polar | 33892256 |
|
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Nudifloramide GC-MS (Non-derivatized) - 70eV, Positive | splash10-0zg0-4900000000-83295d8ad70d3d55646e | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Nudifloramide GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Nudifloramide 40V, Positive-QTOF | splash10-0gdi-9000000000-6078413def74bf56f076 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Nudifloramide 20V, Positive-QTOF | splash10-0zfr-3900000000-36bf456e144d30bcfd8c | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Nudifloramide 30V, Positive-QTOF | splash10-0n4i-9300000000-af2a0597ef17437f3f98 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Nudifloramide 10V, Positive-QTOF | splash10-0udi-0900000000-fb97e1ad0bf72b8f81ef | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Nudifloramide 0V, Positive-QTOF | splash10-0udi-0900000000-3df31b2e00bc83a4103e | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Nudifloramide 30V, Positive-QTOF | splash10-0a4j-9500000000-843d3cb23381be7a74be | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Nudifloramide 10V, Positive-QTOF | splash10-0udi-0900000000-e43af86f5bf6d3983d06 | 2021-09-20 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nudifloramide 10V, Positive-QTOF | splash10-0udi-0900000000-b64dc5db3a8f82da3c8f | 2015-09-15 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nudifloramide 20V, Positive-QTOF | splash10-0ik9-1900000000-7da53351adedc1e67e49 | 2015-09-15 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nudifloramide 40V, Positive-QTOF | splash10-0zir-9300000000-28053d0ec9ded55ae3cf | 2015-09-15 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nudifloramide 10V, Negative-QTOF | splash10-0udi-1900000000-e93df4f3c2c8f4de0322 | 2015-09-15 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nudifloramide 20V, Negative-QTOF | splash10-0pb9-2900000000-36e016881280d17eaae6 | 2015-09-15 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nudifloramide 40V, Negative-QTOF | splash10-0006-9100000000-282653b830a8366d9872 | 2015-09-15 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nudifloramide 10V, Negative-QTOF | splash10-0udi-0900000000-a9caea9efa55584355b6 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nudifloramide 20V, Negative-QTOF | splash10-0zfr-0900000000-d5151b931abbde60cc77 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nudifloramide 40V, Negative-QTOF | splash10-0006-9000000000-6e22a1ee0ef6d5f765b1 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nudifloramide 10V, Positive-QTOF | splash10-0f79-0900000000-3eb746bbbe14af3a4899 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nudifloramide 20V, Positive-QTOF | splash10-0pbi-1900000000-7d7d3dada7dd4c01c714 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nudifloramide 40V, Positive-QTOF | splash10-0udi-9000000000-03f374d0eab3d5245833 | 2021-09-22 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum |
IR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M-H]-) | 2023-02-03 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+H]+) | 2023-02-03 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+Na]+) | 2023-02-03 | FELIX lab | View Spectrum |
|
---|
Biological Properties |
---|
Cellular Locations | - Cytoplasm (predicted from logP)
|
---|
Biospecimen Locations | |
---|
Tissue Locations | |
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Detected and Quantified | 9.00 +/- 4.47 uM | Adult (>18 years old) | Both | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Urine | Detected and Quantified | 6.3 (5.7-10.2) umol/mmol creatinine | Adult (>18 years old) | Both | Normal | - Geigy Scientific ...
- West Cadwell, N.J...
- Basel, Switzerlan...
| details | Urine | Detected and Quantified | 0.71 (0.13-2.88) umol/mmol creatinine | Newborn (0-30 days old) | Both | Normal | | details | Urine | Detected and Quantified | 2.0 (0.67-5.10) umol/mmol creatinine | Children (1-13 years old) | Both | Normal | | details | Urine | Detected and Quantified | 5.75 (1.92-12.63) umol/mmol creatinine | Adult (>18 years old) | Male | Normal | | details | Urine | Detected and Quantified | 4.8 (1.86-13.94) umol/mmol creatinine | Adult (>18 years old) | Female | Normal | | details | Urine | Detected and Quantified | 5.6 (4.6-6.6) umol/mmol creatinine | Adult (>18 years old) | Both | Normal | | details | Urine | Detected and Quantified | 17.23 (12.63-22.96) umol/mmol creatinine | Newborn (0-30 days old) | Both | Normal | | details |
|
---|
Abnormal Concentrations |
---|
| |
Blood | Detected and Quantified | 51.27 +/- 23.66 uM | Adult (>18 years old) | Both | uremia | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal Cancer | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal cancer | | details | Urine | Detected and Quantified | 41.00 (16.00-66.00) umol/mmol creatinine | Adult (>18 years old) | Both | Pellagra | | details |
|
---|
Associated Disorders and Diseases |
---|
Disease References | Uremia |
---|
- Duranton F, Cohen G, De Smet R, Rodriguez M, Jankowski J, Vanholder R, Argiles A: Normal and pathologic concentrations of uremic toxins. J Am Soc Nephrol. 2012 Jul;23(7):1258-70. doi: 10.1681/ASN.2011121175. Epub 2012 May 24. [PubMed:22626821 ]
| Colorectal cancer |
---|
- Brown DG, Rao S, Weir TL, O'Malia J, Bazan M, Brown RJ, Ryan EP: Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool. Cancer Metab. 2016 Jun 6;4:11. doi: 10.1186/s40170-016-0151-y. eCollection 2016. [PubMed:27275383 ]
- Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18. [PubMed:25037050 ]
| Pellagra |
---|
- Creeke PI, Dibari F, Cheung E, van den Briel T, Kyroussis E, Seal AJ: Whole blood NAD and NADP concentrations are not depressed in subjects with clinical pellagra. J Nutr. 2007 Sep;137(9):2013-7. [PubMed:17709435 ]
|
|
---|
Associated OMIM IDs | |
---|
External Links |
---|
DrugBank ID | Not Available |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | FDB023330 |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | 62899 |
---|
KEGG Compound ID | C05842 |
---|
BioCyc ID | Not Available |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | N1-Methyl-2-pyridone-5-carboxamide |
---|
METLIN ID | 7025 |
---|
PubChem Compound | 69698 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 27410 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | M02505 |
---|
MarkerDB ID | MDB00000442 |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Grudzinski, Stefan. Preparation of N-methyl-2-pyridone-5-carboxamide. Roczniki Chemii (1962), 36 1705-8. |
---|
Material Safety Data Sheet (MSDS) | Not Available |
---|
General References | - Carter EG: Quantitation of urinary niacin metabolites by reversed-phase liquid chromatography. Am J Clin Nutr. 1982 Nov;36(5):926-30. [PubMed:6215856 ]
- Patterson JI, Brown RR, Linkswiler H, Harper AE: Excretion of tryptophan-niacin metabolites by young men: effects of tryptophan, leucine, and vitamin B6 intakes. Am J Clin Nutr. 1980 Oct;33(10):2157-67. [PubMed:6448542 ]
- Rutkowski B, Slominska E, Szolkiewicz M, Smolenski RT, Striley C, Rutkowski P, Swierczynski J: N-methyl-2-pyridone-5-carboxamide: a novel uremic toxin? Kidney Int Suppl. 2003 May;(84):S19-21. [PubMed:12694300 ]
- Duranton F, Cohen G, De Smet R, Rodriguez M, Jankowski J, Vanholder R, Argiles A: Normal and pathologic concentrations of uremic toxins. J Am Soc Nephrol. 2012 Jul;23(7):1258-70. doi: 10.1681/ASN.2011121175. Epub 2012 May 24. [PubMed:22626821 ]
- Elshenawy S, Pinney SE, Stuart T, Doulias PT, Zura G, Parry S, Elovitz MA, Bennett MJ, Bansal A, Strauss JF 3rd, Ischiropoulos H, Simmons RA: The Metabolomic Signature of the Placenta in Spontaneous Preterm Birth. Int J Mol Sci. 2020 Feb 4;21(3). pii: ijms21031043. doi: 10.3390/ijms21031043. [PubMed:32033212 ]
|
---|